Latest Breaking News On - Chunrui li - Page 1 : comparemela.com

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoEquecabtagene autoleucelJue wangChunrui liEli lillyInnovent biologicsAdimab incyteInnovent biologics incMd anderson cancer centerAmerican society of hematologyUnion medical collegeTongji medical collegeChina national medical products administrationInstitute of hematologyChinese academy of medical sciences

IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023

/PRNewswire/ IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell.

United statesChunrui liJue wangInnovent biologicsEquecabtagene autoleucelAdimab incyteEli lillyInnovent biologics incUnion medical collegeChina national medical products administrationHuazhong university of science technologyAmerican society of hematologyMd anderson cancer centerTongji medical collegeChinese academy of medical sciencesInstitute of hematology

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes.

Hong kongUnited statesLugui qiuEli lillyInnovent biologicsChunrui liEquecabtagene autoleucelAdimab incyteIncyte corporationPrnewswire innovent biologics incHuazhong university of science technologyTongji medical collegeInternational myeloma societyChina national medical products administrationMd anderson cancer centerChinese academy of medical science hematology hospital

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesHong kongEli lillyAdimab incyteChunrui liLugui qiuEquecabtagene autoleucelIncyte corporationInnovent biologics incMd anderson cancer centerInternational myeloma societyTongji medical collegeChina national medical products administrationHuazhong university of science technologyChinese academy of medical science hematology hospitalComplete response

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody.

Lugui qiuAdimab incyteChunrui liEli lillyA equecabtagene autoleucelEquecabtagene autoleucelInnovent biologicsInnovent biologics incInternational myeloma societyHuazhong university of science technologyChinese academy of medical science hematology hospitalMd anderson cancer centerTongji medical collegeChina national medical products administrationComplete responseAbstract code